Keenova Therapeutics plc
MNKTQDelisted Sep 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567892
Keenova Therapeutics plc was delisted on Sep 6, 2023; its insiders filed their last Form 4 on Jul 23, 2026; 36 institutions reported holding it in 13F filings for Q2 2023, worth $12.4M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Keenova Therapeutics plc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 4 | −31 |
| Shares | 10.5M | 35.0K | 156.6K | −10.3M (−98.5%) |
| Value | $12.4M | $41.4K | $12.5K | −$12.3M (−99.9%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Keenova Therapeutics plc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cantor Fitzgerald, L. P. | 129,080 | $11.0K | 0.00% |
| XTX Topco Ltd | 17,339 | $1.48K | 0.00% |
Sold out (33)
Institutions that held Keenova Therapeutics plc at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (1)
Institutions that held Keenova Therapeutics plc at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 35,048 | $41.4K |